David Fredrickson
EVP, Oncology Business UnitAstraZeneca
PharmaceuticalsView Profile →President, International · Novartis
Patrick Horber is Novartis’s president for International. A physician by training, he developed his commercial career at Roche, Abbott and AbbVie before joining Novartis’s executive committee in 2023.
Last reviewed: Nov 15, 2026
Patrick Horber is Novartis’s president for International. A physician by training, he developed his commercial career at Roche, Abbott and AbbVie before joining Novartis’s executive committee in 2023.
Horber earned his medical degree at the University of Zurich and began his business career in A.T. Kearney’s healthcare practice. From 2005 to 2012 he held headquarters and country-leadership roles at Roche across several therapeutic areas.
He became managing director of Abbott in Switzerland in 2012 and held the corresponding AbbVie role from 2013 to 2015. He then led AbbVie Germany until 2019, followed by responsibility for global marketing and commercial operations.
From 2020 to 2023 Horber was president of US commercial operations for Immunology. He subsequently became AbbVie’s senior vice president and president of Immunology, combining global strategy and commercial-development work with US execution.
Novartis announced his appointment in September 2023, and its annual report records his start as president for International on December 1. The role covers markets outside the United States, including Europe, Asia, Africa, Australasia, Canada and Latin America.
Doctor of Medicine — University of Zurich.